Primary Intracranial Thalamic Leiomyosarcoma: Clinical Report of a Case and Review of the Literature
- Authors
-
-
Jing Jiang
Department of Radiation Oncology, Cancer Center, Beijing Shijitan Hospital, The Beijing University No.9 Clinical College-10 Tieyi Road, Yangfangdian, Haidian District, Beijing 100038, China -
Shunjiang Yu
Department of Radiation Oncology, Cancer Center, Beijing Shijitan Hospital, The Beijing University No.9 Clinical College-10 Tieyi Road, Yangfangdian, Haidian District, Beijing 100038, China -
Li Chen
Department of Radiation Oncology, Cancer Center, Beijing Shijitan Hospital, The Beijing University No.9 Clinical College-10 Tieyi Road, Yangfangdian, Haidian District, Beijing 100038, China -
Feng Gao
Department of Radiation Oncology, Cancer Center, Beijing Shijitan Hospital, The Beijing University No.9 Clinical College-10 Tieyi Road, Yangfangdian, Haidian District, Beijing 100038, China -
Xiaoguang Qiu
Department of Radiation Oncology, Beijing Tiantan Hospital, The Capital Medical University, Beijing 100050, P.R., China
-
- Keywords:
- Leiomyosarcoma, Intracranial, Thalamencephalon, Radiotherapy, Surgery.
- Abstract
-
Purpose:The incidence of the primary intracranial leiomyosarcoma is extremely rare, and few cases have been previously reported worldwide to date. This report was to clarify the potential role of radiotherapy in the management of primary intracranial leiomyosarcoma.
Methods and Materials:This report presented a 49-year old man with a 3-month history of a progressively headache and walking unsteadily. The diagnosis was confirmed with thalamic leiomyosarcomaof high-grade malignancyaccording to the pathologic examination after neurosurgical biopsy. The patient didnt undergo surgical resection because of a high risk death. After biopsy, radiotherapy using 3D-CRT technique to the mass site with 55.8Gy/31f/43d was given accordingly.
Results: The mass didnt reduce much at the end of radiotherapy. The patient refused systemic chemotherapy, he was alive without signs of local relapse and brain side-effectswith 6 month follow-up. After living eleven months and three weeks after radiotherapy, he died of local progression.
Conclusions: Through literature review, the current therapeutic approaches including surgery, radiotherapy as well as chemotherapy appear to have limited effect, but could be beneficious of patients in tumor local control and improvement of the life quality.
- References
-
Anderson WR, Cameron JD, Tsai SH. Primary intracranial leiomyosarcoma. Case report with ultrastructural study. J Neurosurg 1980; 53(3): 401-405. http://dx.doi.org/10.3171/jns.1980.53.3.0401
Paulus W, Slowik F, Jellinger K. Primary intracranial sarcomas: histopathological features of 19 cases. Histopathology 1991; 18(5): 395-402. http://dx.doi.org/10.1111/j.1365-2559.1991.tb00869.x
Lee TT, Page LK. Primary cerebral leiomyosarcoma. Clinical Neurology and Neurosurgery 1997; 99(3): 210-212. http://dx.doi.org/10.1016/S0303-8467(97)00018-8
Hussain S, Nanda A, Fowler M, Ampil FL, Burton GV. Primary intracranial leiomyosarcoma: report of a case and review of the literature. Sarcoma 2006; 2006: 52140-3. http://dx.doi.org/10.1155/SRCM/2006/52140
Brown HG, Burger PC, Olivi A, Sills AK, Barditch PA, Lee RR. Intracranial leiomyosarcoma in a patient with AIDS. Neuroradiology 1999; 41(1): 35-39. http://dx.doi.org/10.1007/s002340050701
Bejjani GK, Stopak B, Schwartz A, Santi R. Primary dural leiomyosarcoma in a patient infected with human immunodeficiency virus: case report. Neurosurgery 1999; 44(1): 199-202. http://dx.doi.org/10.1097/00006123-199901000-00119
Litofsky NS, Pihan G, Corvi F, Smith TW. Intracranial leiomyosarcoma: a neuro oncological consequence of AIDS. J Neurooncol 1998; 40(2): 179-183. http://dx.doi.org/10.1023/A:1006167629968
Blumenthal DT, Raizer JJ, Rosenblum MK, Bilsky MH, Hariharan S, Abrey LE. Primary intracranial neoplasms in patients with HIV. Neurology 1999; 52(8): 1648-1651. http://dx.doi.org/10.1212/WNL.52.8.1648
Sivendran S, Vidal CI, Barginear MF. Primary intracranial leiomyosarcoma in an HIV-infected patient. Int J Clin Oncol 2011; 16(1): 63-6. http://dx.doi.org/10.1007/s10147-010-0110-5
Kaphan E, Eusebio A, Witjas T, Donnet A, Vacher-Coponat H, Figarella-Branger D, Ali Chérif A. Primary leiomyosarcoma of the cavernous sinus associated with EB virus in a kidney graft. Rev Neurol (Paris) 2003; 159(11): 1055-1059.
Louis DN, Richardson EP Jr, Dickersin GR, Petrucci DA, Rosenberg AE, Ojemann RG. Primary intracranial leiomyosarcoma. Case report. J Neurosurg 1989; 71(2): 279-282. http://dx.doi.org/10.3171/jns.1989.71.2.0279
Mathieson CS, St George EJ, Stewart W, Sastry J, Jamal S. Primary intracranial leiomyosarcoma: a case report and review of the literature. Childs Nerv Syst 2009; 25: 1013-1017. http://dx.doi.org/10.1007/s00381-009-0845-3
Aeddula NR, Pathireddy S, Samaha T, Ukena T, Hosseinnezhad A. Primary Intracranial Leiomyosarcoma in an Immunocompetent Adult. J Clin Oncol 2011; 29(14): 407-10. http://dx.doi.org/10.1200/JCO.2010.33.4805
Alijani B, Yousefzade S, Aramnia A, Mesbah A. Primary intracranial leiomyosarcoma. Arch Iran Med 2013; 16(10): 606-7.
Kelley BC, Arnold PM, Grant JA, Newell KL. Primary intracranial β-human chorionic gonadotropin-producing leiomyosarcoma in a 2-year-old immunocompetent child. J Neurosurg Pediatr 2012; 10(2): 121-5. http://dx.doi.org/10.3171/2012.4.PEDS1216
Almubaslat M, Stone JC, Liu L, Xiong Z. Primary intracranial leiomyosarcoma in an immunocompetent patient. Clin Neuropathol 2011; 30(3): 154-7. http://dx.doi.org/10.5414/NPP30154
Fujimoto Y, Hirato J, Wakayama A, Yoshimine T. Primary intracranial leiomyosarcoma in an immunocompetent patient: case report. J Neurooncol 2011; 103(3): 785-90. http://dx.doi.org/10.1007/s11060-010-0450-z
Gupta S, Havens PL, Southern JF, Firat SY, Jogal SS. Epstein-Barr virus- associated intracranial leiomyosarcoma in an HIV-positive adolescent. J Pediatr Hematol Oncol. 2010; 32(4): 144-7. http://dx.doi.org/10.1097/MPH.0b013e3181c80bf3
Suankratay C, Shuangshoti S, Mutirangura A, et al. Epstein-Barr virus infection-associated smooth-muscle tumors in patients with AIDS. Clin Infect Dis 2005; 40(10): 1521-8. http://dx.doi.org/10.1086/429830
Lerdlum S, Lalitanantpong S, Numkarunarunrote N, Chaowanapanja P, Suankratay C, Shuangshoti S. MR imaging of CNS leiomyosarcoma in AIDS patients. J Med Assoc Thai. 2004; 87 Suppl 2: S152-60.
Eckhardt BP, Brandner S, Zollikofer CL, Wentz KU. Primary cerebral leiomyosarcoma in a child. Pediatr Radiol. 2004; 34(6): 495-8. http://dx.doi.org/10.1007/s00247-003-1123-2
Niwa J, Hashi K, Minase T. Radiation induced intracranial leiomyosarcoma: its histopathological features. Acta Neurochir (Wien) 1996; 138(12): 1470-1471. http://dx.doi.org/10.1007/BF01411129
Skullerud K, Stenwig AE, Brandtzaeg P, Nesland JM, Kerty E, Langmoen I, Saeter G.. Intracranial primary leiomyo- sarcoma arising in a teratoma of the pineal area. Clin Neuropathol 1995; 14(4): 245-248.
Asai A, Yamada H, Murata S, Matsuno A, Tsutsumi K, Takemura T, Matsutani M, Takakura K. Primary leiomyosarcoma of the dura mater. Case report. J Neurosurg 1988; 68: 308-311. http://dx.doi.org/10.3171/jns.1988.68.2.0308
Li NY. Primary leiomyosarcoma of the pineal gland--a case report. Zhonghua Zhong Liu Za Zhi. 1987; 9(6): 463-4, 22.
Jhas S, Henriques L, Hawkins C, Bouffet E, Rutka JT. An intracranial leiomyosarcoma in a child with neurofibromatosis type 1. Can J Neurol Sci 2009; 36: 491-495.
- Downloads
- Published
- 2014-12-26
- Issue
- Vol. 3 No. 4 (2014)
- Section
- Articles
How to Cite
Similar Articles
- Gerardo Caruso, Daniele Marino , Maria Caffo , Nanoparticles and CNS Delivery of Therapeutic Agents in the Treatment of Primary Brain Tumors , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Jianwen Lin, Jiali Yang, Jianjun Lu, Xiaoyi Hao, Jiawei Liu, Huali Yan, Huayi Li, Yu Guo, Yong Gu, Quanyong Cheng, Clinical Features of de Novo Lung Neuroendocrine Tumor after Liver Transplantation for Hepatocellular Carcinoma , Journal of Analytical Oncology: Vol. 11 (2022)
- Simona Di Francesco, Raffaele L. Tenaglia, Metabolic Alterations, Vascular Disease and Advanced Prostate Cancer: New Players for Metastatic Advanced Prostate Cancer? , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Abigail Ruiz de Lobera, Aitziber Buqué, Alberto Muñoz, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Eddy I. Gutierrez, Mikel Arruti, Inés Marrodán, Guillermo López-Vivanco, Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Xiaoyi Liu, Lijuan Deng, Haixia Zhang, Tao Zeng, Hua Wang, Yan Zhang, Secretory Kin17 is Correlated with Chemoresistance in Oral Squamous Cell Carcinoma , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Arun Chairmadurai, Harish Chandra Goel, Sandeep Jain, Aklank Jain, Hridayesh Prakash, Ra-SBRT is Potential Immune Adjuvant for Innate Immune Cell Populations in Advance Stage NSCLC Patients , Journal of Analytical Oncology: Vol. 8 (2019)
- Radu Radulescu, Alexandra Totan, Bogdan Calenic, Cosmin Totan , Maria Greabu, Biomarkers of Oxidative Stress, Proliferation, Inflammation and Invasivity in Saliva from Oral Cancer Patients , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- Ravoori Harish Babu, Amritha Prabha Shankar, Geeta S. Narayanan, Ganesh M. Subramanya, B.R. Kiran Kumar, Association of Level III Axillary Lymph Node Positivity with Clinicopathological Characteristics in Breast Cancer , Journal of Analytical Oncology: Vol. 13 (2024)
- Sven Wenske , Philippa Cheetham, Aaron E. Katz, Clinical and Biochemical Outcomes of High-Risk Prostate Cancer Patients treated with Third Generation Prostate Cryosurgery , Journal of Analytical Oncology: Vol. 2 No. 2 (2013)
You may also start an advanced similarity search for this article.